Dana Hilt, MD, PhD

Dr Hilt is chief medical officer of Actinogen Medical. He has held academic neurology positions at the University of Maryland and University of Southern California, where he conducted molecular biological research, taught clinical neurology and basic neurobiology, and cared for patients with neurodegenerative conditions. Dr Hilt has more than 25 years of drug development experience, with extensive experience in phases 1 to 4 development of drugs for conditions including Alzheimer disease, depression, Parkinson disease, amyotrophic lateral sclerosis, multiple sclerosis, schizophrenia, and other conditions.